Low neuropeptide Y in cerebrospinal fluid in bipolar patients is associated with previous and prospective suicide attempts

European Neuropsychopharmacology

Volumn 24, Issue 12, 2014, Pages 1907-1915

  Sandberg, Johan V ^a   Jakobsson, Joel ^a   Pålsson, Erik ^a   Landén, Mikael ^a,b   Mathé, Aleksander A ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Biomarker; Bipolar disorder; Cerebrospinal fluid; Neuropeptide Y; Suicide attempt; Suicide prevention

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; NEUROPEPTIDE Y; VALPROIC ACID; BIOLOGICAL MARKER; PSYCHOTROPIC AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CEREBROSPINAL FLUID ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; HYPOMANIA; IMMUNOREACTIVITY; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MIXED MANIA AND DEPRESSION; PROTEIN CEREBROSPINAL FLUID LEVEL; SUICIDE ATTEMPT; AGE; ANXIETY; CEREBROSPINAL FLUID; COMPLICATION; PERSONALITY; PROSPECTIVE STUDY; SEX DIFFERENCE; YOUNG ADULT;

ADULT; AGE FACTORS; ANXIETY; BIOLOGICAL MARKERS; BIPOLAR DISORDER; FEMALE; HUMANS; MALE; NEUROPEPTIDE Y; PERSONALITY; PROSPECTIVE STUDIES; PSYCHOTROPIC DRUGS; SEX FACTORS; SUICIDE, ATTEMPTED; YOUNG ADULT;

EID: 84918831141     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2014.10.006     Document Type: Article

References (55)

1. Apter A., van Praag H.M., Plutchik R., Sevy S., Korn M., Brown S.L. Interrelationships among anxiety, aggression, impulsivity, and mood: a serotonergically linked cluster?. Psychiatry Res. 1990, 32:191-199.
2. Baldessarini R.J., Pompili M., Tondo L. Suicide in bipolar disorder: risks and management. CNS Spectr. 2006, 11:465-471.
3. Beautrais A.L., Joyce P.R., Mulder R.T., Fergusson D.M., Deavoll B.J., Nightingale S.K. Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: a case-control study. Am. J. Psychiatry 1996, 153:1009-1014.
4. Berrettini W.H., Oxenstierna G., Sedvall G., Nurnberger J.I., Gold P.W., Rubinow D.R., Goldin L.R. Characteristics of cerebrospinal fluid neuropeptides relevant to clinical research. Psychiatry Res. 1988, 25:349-359.
5. Björnebekk A., Mathé A.A., Brene S. The antidepressant effects of running and escitalopram are associated with levels of hippocampal NPY and Y1 receptor but not cell proliferation in a rat model of depression. Hippocampus 2010, 20:820-828.
6. Burbach J.P. Neuropeptides and cerebrospinal fluid. Ann. Clin. Biochem. 1982, 19(Pt 4):269-277.
7. Busch K.A., Fawcett J., Jacobs D.G. Clinical correlates of inpatient suicide. J. Clin. Psychiatry 2003, 64:14-19.
8. Caberlotto L., Hurd Y.L. Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder. Neuroreport 1999, 10:1747-1750.
9. Caberlotto L., Hurd Y.L. Neuropeptide Y Y(1) and Y(2) receptor mRNA expression in the prefrontal cortex of psychiatric subjects. Relationship of Y(2) subtype to suicidal behavior. Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 2001, 25:91-97.
10. Choi H.Y., Kim S.I., Yun K.W., Kim Y.C., Lim W.J., Kim E.J., Ryoo J.H. A study on correlation between anxiety symptoms and suicidal ideation. PsychiatryInvestig. 2011, 8:320-326.
11. Cohen H., Liu T.M., Kozlovsky N., Kaplan Z., Zohar J., Mathé A.A. The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder. Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 2012, 37:350-363.
12. Coryell W., Young E.A. Clinical predictors of suicide in primary major depressive disorder. J. Clin. Psychiatry 2005, 66:412-417.
13. Ehlers C.L., Li T.K., Lumeng L., Hwang B.H., Somes C., Jimenez P., Mathé A.A. Neuropeptide Y levels in ethanol-naive alcohol-preferring and nonpreferring rats and in Wistar rats after ethanol exposure. Alcohol. Clin. Exp. Res. 1998, 22:1778-1782.
14. Gustavsson J.P., Bergman H., Edman G., Ekselius L., von Knorring L., Linder J. Swedish universities Scales of Personality (SSP): construction, internal consistency and normative data. Acta Psychiatr. Scand. 2000, 102:217-225.
15. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 2004, 38:213-224.
16. Heilig M., Zachrisson O., Thorsell A., Ehnvall A., Mottagui-Tabar S., Sjögren M., Åsberg M., Ekman R., Wahlestedt C., Ågren H. Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. J. Psychiatr. Res. 2004, 38:113-121.
17. Hou C., Jia F., Liu Y., Li L. CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder. Brain Res. 2006, 1095:154-158.
18. Husum H., Mathé A.A. Early life stress changes concentrations of neuropeptide Y and corticotropin-releasing hormone in adult rat brain. Lithium treatment modifies these changes. Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 2002, 27:756-764.
19. Isometsa E.T., Heikkinen M.E., Marttunen M.J., Henriksson M.M., Aro H.M., Lönnqvist J.K. The last appointment before suicide : is suicide intent communicated. Am. J. Psychiatry 1995, 152:919-922.
20. Janelidze S., Ventorp F., Erhardt S., Hansson O., Minthon L., Flax J., Samuelsson M., Träskman-Bendz L., Brundin L. Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters. Psychoneuroendocrinology 2013, 38:853-862.
21. Jimenez-Vasquez P.A., Diaz-Cabiale Z., Caberlotto L., Bellido I., Overstreet D., Fuxe K., Mathé A.A. Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y(1) receptor gene expressions in hippocampus and hypothalamus of Flinders Sensitive Line rat model of depression. Eur. Neuropsychopharmacol.: J.Eur. Coll. Neuropsychopharmacol. 2007, 17:298-308.
22. Jimenez-Vasquez P.A., Mathé A.A., Thomas J.D., Riley E.P., Ehlers C.L. Early maternal separation alters neuropeptide Y concentrations in selected brain regions in adult rats. Dev. Brain Res. 2001, 131:149-152.
23. Kuromitsu J., Yokoi A., Kawai T., Nagasu T., Aizawa T., Haga S., Ikeda K. Reduced neuropeptide Y mRNA levels in the frontal cortex of people with schizophrenia and bipolar disorder. Brain research. Gene Expr. Patterns 2001, 1:17-21.
24. Lindell S.G., Schwandt M.L., Sun H., Sparenborg J.D., Björk K., Kasckow J.W., Sommer W.H., Goldman D., Higley J.D., Suomi S.J., Heilig M., Barr C.S. Functional NPY variation as a factor in stress resilience and alcohol consumption in rhesus macaques. Arch. Gen. Psychiatry 2010, 67:423-431.
25. Lindqvist D., Janelidze S., Erhardt S., Träskman-Bendz L., Engström G., Brundin L. CSF biomarkers in suicide attempters--a principal component analysis. Acta Psychiatr. Scand. 2011, 124:52-61.
26. Mathé A.A., Husum H., El Khoury A., Jimenez-Vasquez P., Gruber S.H.M., Wortwein G., Nikisch G., Baumann P., Ågren H., Andersson W., Södergren A., Angelucci F. Search for biological correlates of depression and mechanisms of action of antidepressant treatment modalities. Do neuropeptides play a role?. Physiol. Behav. 2007, 92:226-231.
27. Mathé A.A., Jousisto-Hanson J., Stenfors C., Theodorsson E. Effect of lithium on tachykinins, calcitonin gene-related peptide, and neuropeptide Y in rat brain. J. Neurosci. Res. 1990, 26:233-237.
28. Mathé A.A., Rudorfer M.V., Stenfors C., Manji H.K., Potter W.C., Theodorsson E. Effects of electroconvulsive treatment on somatostatin, neuropeptide Y, endothelin, and neurokinin A concentrations in cerebrospinal fluid of depressed patients: a pilot study. Depression 1996, 3:250-256.
29. Merikangas K.R., Jin R., He J.P., Kessler R.C., Lee S., Sampson N.A., Viana M.C., Andrade L.H., Hu C., Karam E.G., Ladea M., Medina-Mora M.E., Ono Y., Posada-Villa J., Sagar R., Wells J.E., Zarkov Z. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch. Gen. Psychiatry 2011, 68:241-251.
30. Mickey B.J., Zhou Z., Heitzeg M.M., Heinz E., Hodgkinson C.A., Hsu D.T., Langenecker S.A., Love T.M., Pecina M., Shafir T., Stohler C.S., Goldman D., Zubieta J.K. Emotion processing, major depression, and functional genetic variation of neuropeptide Y. Arch. Gen. Psychiatry 2011, 68:158-166.
31. Nikisch G., Ågren H., Eap C.B., Czernik A., Baumann P., Mathé A.A. Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram. Int. J. Neuropsychopharmacol. 2005, 8:403-410.
32. Nikisch G., Baumann P., Liu T., Mathé A.A. Quetiapine affects neuropeptide Y and corticotropin-releasing hormone in cerebrospinal fluid from schizophrenia patients: relationship to depression and anxiety symptoms and to treatment response. Int. J. Neuropsychopharmacol. 2012, 15:1051-1061.
33. Nikisch G., Mathé A.A. CSF monoamine metabolites and neuropeptides in depressed patients before and after electroconvulsive therapy. Eur. Psychiatry: J. Assoc. Eur. Psychiatr. 2008, 23:356-359.
34. Ohring R., Apter A., Ratzoni G., Weizman R., Tyano S., Plutchik R. State and trait anxiety in adolescent suicide attempters. J. Am. Acad. Child Adolesc. Psychiatry 1996, 35:154-157.
35. Ordway G.A., Stockmeier C.A., Meltzer H.Y., Overholser J.C., Jaconetta S., Widdowson P.S. Neuropeptide Y in frontal cortex is not altered in major depression. J. Neurochem. 1995, 65:1646-1650.
36. Overstreet D.H., Friedman E., Mathé A.A., Yadid G. The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci. Biobehav. Rev. 2005, 29:739-759.
37. Pompili M., Rihmer Z., Akiskal H., Amore M., Gonda X., Innamorati M., Lester D., Perugi G., Serafini G., Telesforo L., Tatarelli R., Girardi P. Temperaments mediate suicide risk and psychopathology among patients with bipolar disorders. Compr. Psychiatry 2012, 53:280-285.
38. Roy A. Neuropeptides in relation to suicidal behavior in depression. Neuropsychobiology 1993, 28:184-186.
39. Rydén E., Thase M.E., Straht D., Åberg-Wistedt A., Bejerot S., Landén M. A history of childhood attention-deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD. Acta Psychiatr. Scand. 2009, 120:239-246.
40. Ryding E., Lindström M., Träskman-Bendz L. The role of dopamine and serotonin in suicidal behaviour and aggression. Prog. Brain Res. 2008, 172:307-315.
41. Sachs G.S., Thase M.E., Otto M.W., Bauer M., Miklowitz D., Wisniewski S.R., Lavori P., Lebowitz B., Rudorfer M., Frank E., Nierenberg A.A., Fava M., Bowden C., Ketter T., Marangell L., Calabrese J., Kupfer D., Rosenbaum J.F. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol. Psychiatry 2003, 53:1028-1042.
42. Sah R., Ekhator N.N., Strawn J.R., Sallee F.R., Baker D.G., Horn P.S., Geracioti T.D. Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder. Biol. Psychiatry 2009, 66:705-707.
43. Serafini G., Pompili M., Lindqvist D., Dwivedi Y., Girardi P. The role of neuropeptides in suicidal behavior: a systematic review. BioMed Res. Int. 2013, 2013:687575.
44. Serafini G., Pompili M., Elena Seretti M., Stefani H., Palermo M., Coryell W., Girardi P. The role of inflammatory cytokines in suicidal behavior: a systematic review. Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol. 2013, 23:1672-1686.
45. Slawecki C.J., Jimenez-Vasquez P., Mathé A.A., Ehlers C.L. Effect of ethanol on brain neuropeptides in adolescent and adult rats. J. Stud. Alcohol 2005, 66:46-52.
46. Slawecki C.J., Thorsell A.K., El Khoury A., Mathé A.A., Ehlers C.L. Increased CRF-like and NPY-like immunoreactivity in adult rats exposed to nicotine during adolescence: relation to anxiety-like and depressive-like behavior. Neuropeptides 2005, 39:369-377.
47. Sommer W.H., Lidström J., Sun H., Passer D., Eskay R., Parker S.C.J., Witt S.H., Zimmermann U.S., Nieratschker V., Rietschel M., Margulies E.H., Palkovits M., Laucht M., Heilig M. Human NPY promoter variation rs16147:T>C as a moderator of prefrontal NPY gene expression and negative affect. Hum. Mutat. 2010, 31:E1594-E1608.
48. Thorsell A., Michalkiewicz M., Dumont Y., Quirion R., Caberlotto L., Rimondini R., Mathé A.A., Heilig M. Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc. Natl. Acad. Sci. USA 2000, 97:12852-12857.
49. Tidemalm D., Långström N., Lichtenstein P., Runeson B. Risk of suicide after suicide attempt according to coexisting psychiatric disorder: swedish cohort study with long term follow-up. BMJ 2008, 337:a2205.
50. Träskman-Bendz L., Ekman R., Regnéll G., Ohman R. HPA-related CSF neuropeptides in suicide attempters. Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol. 1992, 2:99-106.
51. Walker B.M., Drimmer D.A., Walker J.L., Liu T., Mathé A.A., Ehlers C.L. Effects of prolonged ethanol vapor exposure on forced swim behavior, and neuropeptide Y and corticotropin-releasing factor levels in rat brains. Alcohol 2010, 44:487-493.
52. Westrin A., Ekman R., Träskman-Bendz L. Alterations of corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt. Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol. 1999, 9:205-211.
53. Widdowson P.S., Ordway G.A., Halaris A.E. Reduced neuropeptide Y concentrations in suicide brain. J. Neurochem. 1992, 59:73-80.
54. Wu G., Feder A., Wegener G., Bailey C., Saxena S., Charney D., Mathé A.A. Central functions of neuropeptide Y in mood and anxiety disorders. Expert Opin. Ther. Targets 2011, 15:1317-1331.
55. Zhou Z., Zhu G., Hariri A.R., Enoch M.A., Scott D., Sinha R., Virkkunen M., Mash D.C., Lipsky R.H., Hu X.Z., Hodgkinson C.A., Xu K., Buzas B., Yuan Q., Shen P.H., Ferrell R.E., Manuck S.B., Brown S.M., Hauger R.L., Stohler C.S., Zubieta J.K., Goldman D. Genetic variation in human NPY expression affects stress response and emotion. Nature 2008, 452:997-1001.